Skip to main content
Vcanbio Cell & Gene Engineering Corp., Ltd logo

Vcanbio Cell & Gene Engineering Corp., Ltd — Investor Relations & Filings

Ticker · 600645 ISIN · CNE000000545 LEI · 300300FLWFDJPQYVAZ24 Shanghai Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,580 across all filing types
Latest filing 2018-04-03 AGM Information
Country CN China
Listing Shanghai Stock Exchange 600645

About Vcanbio Cell & Gene Engineering Corp., Ltd

https://www.vcanbio.com/

Vcanbio Cell & Gene Engineering Corp., Ltd. specializes in the fields of cell therapy, gene technology, and precision medicine. The company operates a comprehensive business model centered on the storage of hematopoietic and mesenchymal stem cells, providing long-term bio-banking services for cord blood and other biological tissues. Its technical portfolio includes advanced genetic testing services, such as prenatal screening and oncology diagnostics, alongside the development of cell-based therapeutic products. Vcanbio maintains a network of specialized laboratories and storage facilities to support clinical research and personalized healthcare applications. The organization focuses on translating biotechnological advancements into clinical solutions, emphasizing quality control in cell processing and genomic analysis to serve the evolving needs of the regenerative medicine and diagnostic sectors.

Recent filings

Filing Released Lang Actions
2018年第四次临时股东大会会议资料
AGM Information Classification · 95% confidence The document is titled as materials for the 2018 fourth extraordinary shareholders meeting (临时股东大会) of 中源协和细胞基因工程股份有限公司. It contains detailed meeting agenda, voting procedures, and a comprehensive proposal regarding the transfer of 67% equity in 浙江赛尚医药科技有限公司. The document includes transaction details, parties involved, financial data of the target company, contractual terms, and the impact of the transaction on the company. It is clearly a meeting material document prepared for the shareholders to review and vote on the equity transfer proposal. This matches the definition of AGM Information (AGM-R), which includes presentations and materials shared during the Annual General Meeting or Extraordinary General Meeting. The document is not a report itself (like an annual report or interim report), nor is it a simple announcement or voting result. It is a detailed meeting material document for a shareholders meeting. The document length (7976 characters) supports it being a full meeting material rather than a brief announcement.
2018-04-03 Chinese
浙江赛尚医药科技有限公司审计报告
Regulatory Filings
2018-04-03 Chinese
关于下属子公司收到政府补助资金的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from the company 中源协和细胞基因工程股份有限公司 regarding government subsidies received by its subsidiaries. It details the amounts, sources, and accounting treatment of these subsidies. The document is relatively short (2437 characters) and does not contain comprehensive financial statements or detailed financial analysis. It is a specific announcement about government grants and their accounting impact, not a full financial report or audit. It does not fit categories like Annual Report, Interim Report, or Earnings Release. It is also not a regulatory certification or officer attestation. The content is a regulatory announcement about financial subsidies, best classified under Regulatory Filings (RNS) as it does not fit more specific categories.
2018-04-03 Chinese
关于为关联方提供担保暨关联交易的进展公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by the company 中源协和细胞基因工程股份有限公司 regarding the progress of guarantees provided to related parties and related party transactions. It details specific loan guarantees, amounts, approvals by shareholders' meetings, and the status of these guarantees. The document is relatively short (1191 characters) and focuses on financial guarantees and related party transactions rather than presenting full financial statements or audit results. It is not an annual or interim report, nor an earnings release. It is not a regulatory certification or a report publication announcement. The content fits best with a Capital/Financing Update (CAP) as it concerns updates on company financing activities, specifically guarantees and related party financial commitments.
2018-03-30 Chinese
关于转让浙江赛尚医药科技有限公司67%股权的进展公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by the company regarding the progress of a share transfer transaction involving 67% equity of a subsidiary company. It details the signing of a share transfer agreement, payment delays, and subsequent commitments by the buyer. The document is short (663 characters) and focuses on updating shareholders and the market about the status of a capital transaction rather than presenting financial results or detailed reports. It does not contain financial statements or detailed financial analysis. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes.
2018-03-30 Chinese
关于召开2018年第四次临时股东大会的通知
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice about convening the 2018 fourth extraordinary general meeting of shareholders, detailing the meeting date, voting methods, agenda items, and procedural instructions. It includes information about the meeting logistics, voting system, and proxy authorization form. There is no financial data, earnings, or report content. The document is an announcement related to a shareholder meeting rather than the meeting materials or results themselves. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or possibly Proxy Solicitation & Information Statement (PSI). However, since it is a notice of the meeting and voting procedures rather than solicitation materials or voting results, it is best classified as a Proxy Solicitation & Information Statement (PSI). The document length is under 5,000 characters and it is a meeting notice with proxy details, not a report or results announcement.
2018-03-28 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.